Join StocksJar.com -Get 7 Days Free trial

Insulet (PODD) Stock Price & AI Analysis

NYSE
USA

$265.46

-$1.06
(-0.45%)

Subscribe to get
AI Score

  • Market Cap 18.62B
  • Volume 443,120
  • Avg Volume 578.15K
  • Target Price $233.07
  • 52W Range 160.19 - 279.40
  • RSI (14) 59.87
  • Beta 1.22
  • PEG Ratio 1.96
  • SMA 20 -0.3600
  • SMA 50 7.58
  • SMA 200 30.70
  • Insider Owner 0.56%
  • Insider Trans -7.04%
  • Institution Owner 101.98%
  • Institution Trans -1.53%
  • Short Interest 3.01%
  • EPS next Y 15.69

Insulet Company Profile

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insulet | Latest news

Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your...

Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your...

We recently compiled a list of the 7 Best Diabetes Stocks To Buy Now. In this article, we are going...

Insider Monkey - 4 months ago

MDT or PODD: Which Is the Better Value Stock Right Now?

MDT or PODD: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Medtronic (MDT) and...

Zacks - 1 year ago

Insulet (PODD): A Significantly Undervalued Gem in the Medical Devices Industry?

Insulet (PODD): A Significantly Undervalued Gem in the Medical Devices Industry?

Insulet Corp (NASDAQ:PODD) recently experienced a daily gain of 3.63%, despite a significant 3-month...

GuruFocuscom - 1 year ago

Down -21.98% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround

Down -21.98% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround

Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy...

Zacks - 1 year ago

Does Insulet (PODD) Face Challenges from the New Weight Loss Drug?

Does Insulet (PODD) Face Challenges from the New Weight Loss Drug?

ClearBridge Investments, an investment management company, released its “ClearBridge Select...

Insider Monkey - 1 year ago

Is Insulet (PODD) Significantly Undervalued? A Comprehensive Valuation Analysis

Is Insulet (PODD) Significantly Undervalued? A Comprehensive Valuation Analysis

Insulet Corp (NASDAQ:PODD) witnessed a daily loss of -3.18% and a 3-month loss of -28.58%, with its...

GuruFocuscom - 1 year ago

Insulet (PODD) Stock Moves -0.34%: What You Should Know

Insulet (PODD) Stock Moves -0.34%: What You Should Know

Insulet (PODD) closed at $177.41 in the latest trading session, marking a -0.34% move from the prior...

Zacks - 8 months ago

Insulet’s (PODD) Sales And Margins Surpassed Expectations

Insulet’s (PODD) Sales And Margins Surpassed Expectations

Brown Capital Management, an investment management company, released its “The Brown Capital...

Insider Monkey - 3 months ago

Decoding Insulet Corp (PODD): A Strategic SWOT Insight

Decoding Insulet Corp (PODD): A Strategic SWOT Insight

Insulet Corp (NASDAQ:PODD) showcases robust revenue growth, with a 23.2% increase in total revenue...

GuruFocuscom - 4 months ago

Insulet (PODD): A Hidden Gem Significantly Undervalued

Insulet (PODD): A Hidden Gem Significantly Undervalued

Insulet Corp (NASDAQ:PODD) recently experienced a -1.26% loss, and a significant 3-month loss of...

GuruFocuscom - 1 year ago